Damloran Pharmaceutical (XTEH:DAML1) Long-Term Debt: IRR0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTEH:DAML1 Damloran Pharmaceutical XTEH:DAML1
27 GF Score
Price IRR10,100.00
View Full Analysis

What is Damloran Pharmaceutical Long-Term Debt?

Damloran Pharmaceutical XTEH:DAML1 27 Long-Term Debt is IRR0.00 Mil as of . 20. GuruFocus rates XTEH:DAML1 with a GF Score™ of 27/100.

Damloran Pharmaceutical's Long-Term Debt for the quarter that ended in . 20 was IRR0.00 Mil.

Damloran Pharmaceutical  (XTEH:DAML1) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Damloran Pharmaceutical Long-Term Debt Related Terms

Damloran Pharmaceutical Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Damloran Pharmaceutical's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Damloran Pharmaceutical Long-Term Debt Chart

Damloran Pharmaceutical Annual Data
Trend
Long-Term Debt

Damloran Pharmaceutical Semi-Annual Data
Long-Term Debt
XTEH:DAML1
27GF Score
Damloran Pharmaceutical XTEH:DAML1
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of IRR0.00 Mil mean?
Damloran Pharmaceutical (XTEH:DAML1) has a Long-Term Debt of IRR0.00 Mil as of . 20.
Is Damloran Pharmaceutical's Long-Term Debt too high?
Damloran Pharmaceutical's current Long-Term Debt is IRR0.00 Mil. Overall, Damloran Pharmaceutical has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Damloran Pharmaceutical's Long-Term Debt compare to IMNPQ?
Damloran Pharmaceutical's Long-Term Debt of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Damloran Pharmaceutical's current Long-Term Debt is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Damloran Pharmaceutical stock overvalued right now?
Damloran Pharmaceutical (XTEH:DAML1) has a current Long-Term Debt of IRR0.00 Mil. The current Long-Term Debt is IRR0.00 Mil. Damloran Pharmaceutical's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Damloran Pharmaceutical (XTEH:DAML1), the current Long-Term Debt is IRR0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Damloran Pharmaceutical Business Description

Address No.4, Parvin Alley, West Fatemi Avenue, Tehran, IRN
Damloran Pharmaceutical manufactures and markets livestock and poultry pharmaceuticals. The Company offers animal health products to protect and improve health and hygiene of society to treat and to enhance the quality of animals' life.
27GF Score

Get the complete analysis for XTEH:DAML1

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

IRR10,100.00
Price